Are diagnostic technologies for alzheimer’s disease and dementia cost-effective? A systematic review of economic evaluations
While many studies were of high quality, heterogeneity in study objectives, design, and outcomes restricted evidence synthesis. Future research should ensure methodological consistency, transparent cost reporting, and integration of new treatment frameworks to improve the policy relevance and reliability of economic evidence for AD diagnostics.
Authors
- Cyprian M. Mostert (ORCID: https://orcid.org/0000-0002-1911-9373)
- Olivia Haldenby
- Shehzad Ali (ORCID: https://orcid.org/0000-0002-2988-5231)
- Juwairiya Fatima Ahmad
- Arshaan Asim Muhammad
- Munira Kashem
Institutions
- Western University (CA)
- Health Canada (CA)
- Centre for Addiction and Mental Health (CA)
- Aga Khan University Nairobi (KE)
- University of York (GB)
- McMaster University (CA)
- Macquarie University (AU)
Publication Details
- Journal
- Alzheimer s Research & Therapy
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1186/s13195-025-01933-1
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00